all report title image
  • Published On : Mar 2022
  • Code : CMI4955
  • Industry : Medical Devices
  • Pages : 162
  • Formats :

Scars form as a result of the healing process of the body. The body creates tissue to repair damaged skin and fill gaps caused by an injury. Accident, burns, surgery, acne, and illness can develop scars on the body.

To close a wound quickly after an incision, skin cells multiply and synthesize the elements that surround them, such as collagen or elastin. The scar is formed as a result of the formation of new fibrous tissue. Any surgical incision results in the formation of a scar, the final appearance of which will be determined by a number of factors, including its anatomical site, operative techniques, sutures, intrinsic patient-related factors, extrinsic factors such as environmental factors.

U.S. Post-Surgical Scar Treatment Market - Impact of the Coronavirus (COVID-19) Pandemic

The number of surgeries such as open heart surgery, C-sections, appendectomy, mastectomy, or knee replacement surgery can cause scars on the body. In 2020, the COVID-19 pandemic disrupted delivery of healthcare services around the U.S., including delays in various elective surgical procedures. For instance, according to an article published in JAMA Network, Journal of the American Medical Association is a peer-reviewed medical journal, in December 2021, a cohort study of pediatric and adult patients from January 1, 2019 to January 30, 2021, undergoing surgery in the U.S. was conducted. Moreover, the study's findings revealed a 48.0% decrease in total surgical procedure volume immediately following the March 2020 recommendation to cancel elective surgical procedures. Thus, the preceding example suggests that there was a decrease in the overall number of surgical procedures performed in the U.S., which may have resulted in a decrease in the treatment of post-surgical scars on the body. Therefore, the COVID-19 impact is expected to hinder the growth of the U.S. post-surgical scar treatment market over the forecast period.

The U.S. post-surgical scar treatment market is estimated to be valued at US$ 2,680.1 Mn in 2022, and is expected to exhibit a CAGR of 10.1% over the forecast period (2022-2030).

Increasing number of surgical procedures in the U.S. is the major factor that is expected to drive growth of the U.S. post-surgical scar treatment market over the forecast period.

The increasing number of surgical procedures in the U.S. population is expected to drive growth of the U.S. post-surgical scar treatment market, over the forecast period. According to the National Center for Biotechnology Information (NCBI), 2020, the following graph shows the number of plastic surgeries carried out in the year 2017, 2018, 2019, and 2020, in the U.S.

Figure 1: Number of Plastic Surgeries in the U.S.

U.S. Post-Surgical Scar Treatment  | Coherent Market Insights

Increasing number of product launches by the market players is expected to drive the market growth over the forecast period

Market players are indulged in launching number of innovative products for the treatment of scars. This is expected to drive growth of the U.S. post-surgical scar treatment market, over the forecast period. For instance, on November 11, 2021, Estas Beauty, a manufacturer of skin care products, launched three products i.e., ‘Morning Massage’ cleansing oil with vitamin E & primrose; a ‘Daily Dose’ vitamin E & C cream serum; and ‘Sleep Salve’ silicone & Vitamin E mask. All the three products has silicone, which increases hydration and reduces collagen production, itching, and discomfort. The product is used for patients who undergo surgical procedures and develop scarring.

CMI table icon

U.S. Post-Surgical Scar Treatment Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 2,680.1 Mn
Historical Data for: 2017 to 2021 Forecast Period: 2022 to 2030
Forecast Period 2020 to 2030 CAGR: 10.1% 2030 Value Projection: US$ 5,769.4 Mn
Geographies covered:
  • North America: U.S. 
Segments covered:
  • By Product Type: Silicone sheets & Patches, Surgical tapes, Strips, Gels & Creams, Others
  • By Channel: OTC, Rx
  • By Scar Type: Atrophic Scars, Hypertrophic Scars, Keloid Scars, Contracture Scars
  • By Surgery Type: Caesarean Section, Joint Replacement, Appendectomy, Heart Surgery, Breast surgery, Others
  • By End User: Ambulatory Surgical Centers, Clinics, Home Care Settings, Hospitals
Companies covered:

Smith & Nephew Plc., 3M, Cardinal Health, Merz Pharma, Biodermis, Scar Heal, Inc., Mölnlycke Health Care AB, Implantech, Covalon Technologies Ltd., Bio Med Sciences, Polymer Science, Inc., and Neodyne Biosciences, Inc.

Growth Drivers:
  • Increasing number of surgical procedures in the U.S. population
  • Increasing number of product launches by the market players
Restraints & Challenges:
  • Availability of alternative treatments such as laser treatment

Figure 2: U.S. Post-Surgical Scar Treatment Market Share (%) Analysis, By Product Type, 2022

U.S. Post-Surgical Scar Treatment  | Coherent Market Insights

U.S. Post-Surgical Scar Treatment Market – Restraints

The availability of other treatments such as laser treatment for post-surgical scars is expected to hamper growth of the U.S. post-surgical scar treatment market over the forecast period. According to the article published in the American Society of Plastic Surgeons: 2020, laser therapy is a safe and effective treatment for scars. According to the same source, dermatologists can use a laser to reduce a scar's appearance and minimize pain and itching. Laser treatment can also prevent scars from forming after surgery. Laser treatment also helps to stimulate new and healthy skin growth.

U.S. Post-Surgical Scar Treatment Market – Competitive Landscape

Major players operating in the U.S. post-surgical scar treatment market include Smith & Nephew Plc., 3M, Cardinal Health, Merz Pharma, Biodermis, Scar Heal, Inc., Mölnlycke Health Care AB, Implantech, Covalon Technologies Ltd., Bio Med Sciences, Polymer Science, Inc., and Neodyne Biosciences, Inc.

Any burn, injury, or trauma such as surgeries can cause a scar on the skin. Scarring is a natural healing process, which occurs after an injury. Its appearance and treatment depend on multiple factors such as the depth and size of the wound or the cut. It also depend upon the location of the wound, age, sex, and genes. There are various types of scars such as keloid scars, contracture scars, acne scars, and hypertrophic scars. Keloid scars are formed due to an over-aggressive healing process. They usually extend beyond their original location of the injury. Treatment of keloid scars include surgery, steroid injections, silicone sheets, and others. Hypertrophic scars are raised red scars and treatment of these scars include injection of steroids or silicone sheets.

Market Dynamics

Market players are engaged in inorganic growth activities such as acquisitions, and this is expected to drive growth of the U.S. post-surgical scar treatment market, over the forecast period. For instance, in April 2019, Merz, a company involved in aesthetics and neurotoxins, and Laboratoire HRA Pharma SAS, an innovative U.S. consumer healthcare company, entered into an agreement to acquire the asset purchase agreement, according to which HRA Pharma will acquire the U.S. rights to the Mederma brand of Merz, which includes products across the scar care, stretch marks, and skincare categories.

Moreover, in October 2019, 3M, a multinational conglomerate corporation operating in the fields of industry, worker safety, health care, and consumer goods, completed the acquisition of Acelity, Inc., a medical device company, to expand its surgical applications business, which include advanced wound care and specialty surgical applications marketed under the KCI brand (PROMOGRAN) in the developed economies such as the U.S.

Key features of the study:

  • This report provides an in-depth analysis of the S. post-surgical scar treatment market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the U.S. post-surgical scar treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Smith & Nephew Plc., 3M, Cardinal Health, Merz Pharma, Biodermis, Scar Heal, Inc., Mölnlycke Health Care AB, Implantech, Covalon Technologies Ltd., Bio Med Sciences, Polymer Science, Inc., and Neodyne Biosciences, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The U.S. post-surgical scar treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the U.S. post-surgical scar treatment market

Detailed Segmentation:

  • U.S. Post-Surgical Scar Treatment Market, By Product Type:
    • Silicone sheets & Patches
    • Surgical tapes
    • Strips
    • Gels & Creams
    • Others
  • U.S. Post-Surgical Scar Treatment Market, By Channel:
    • OTC
    • Rx
  • U.S. Post-Surgical Scar Treatment Market, By Scar Type:
    • Atrophic Scars
    • Hypertrophic Scars
    • Keloid Scars
    • Contracture Scars
  • U.S. Post-Surgical Scar Treatment Market, By Surgery Type:
    • Caesarean Section
    • Joint Replacement
    • Appendectomy
    • Heart Surgery
    • Breast surgery
    • Others
  • U.S. Post-Surgical Scar Treatment Market, By End User:
    • Ambulatory Surgical Centers
    • Clinics
    • Home Care Settings
    • Hospitals
  • Company Profiles
    • Smith & Nephew Plc. *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • 3M
    • Cardinal Health
    • Merz Pharma
    • Biodermis
    • Scar Heal, Inc.
    • Mölnlycke Health Care AB
    • Implantech
    • Covalon Technologies Ltd.
    • Bio Med Sciences
    • Polymer Science, Inc.
    • Neodyne Biosciences, Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The U.S. post-surgical scar treatment market is expected to exhibit a CAGR of 10.1% during the forecast period (2022-2030).
The market is estimated to be valued at US$ 2,680.1 Mn in 2022.
The prominent players operating in the U.S. post-surgical scar treatment market include Smith & Nephew Plc., 3M, Cardinal Health, Merz Pharma, Biodermis, Scar Heal, Inc., Mölnlycke Health Care AB, Implantech, Covalon Technologies Ltd., Bio Med Sciences, Polymer Science, Inc., and Neodyne Biosciences, Inc.
The market is expected to be valued at US$ 5,769.4 Mn in 2030.
An increasing number of surgical procedures in the U.S. population, and increasing number of product launches by the market players are some of the driving factors, which are expected to drive growth of the market.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo